Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.32 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10709879 | 0.93 | HSD11B1 (0.31) | IDH1HSD11B1HSD11B2ALDH1A1 | |
| SCHEMBL20043804 | 0.91 | HSD11B1 (0.34) | IDH1HSD11B1HSD11B2 | |
| SCHEMBL20824865 | 0.88 | HSD11B1 (0.35) | HSD11B1HSD11B2ALDH1A1 | |
| SCHEMBL21709639 | 0.88 | HSD11B1 (0.35) | HSD11B1HSD11B2ALDH1A1 | |
| SCHEMBL11597749 | 0.81 | SLC1A2 (0.39) | MEN1KMT2A | |
| SCHEMBL504027 | 0.81 | SLC1A2 (0.39) | MEN1KMT2A | |
| SCHEMBL2277633 | 0.81 | SLC1A2 (0.39) | MEN1KMT2A | |
| SCHEMBL504028 | 0.81 | SLC1A2 (0.39) | MEN1KMT2A | |
| SCHEMBL3706333 | 0.79 | EPHX1 (0.40) | IDH1HSD11B1HSD11B2MEN1ALDH1A1 | |
| SCHEMBL8545394 | 0.79 | POLB (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993000359-A1 | MODIFIED PEPTIDES TRANSPORTABLE INTO THE CENTRAL NERVOUS SYSTEM | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-01-07 | — | — | WO | disclosed |